High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801 (Q73825066)
Jump to navigation
Jump to search
scientific article published on 01 May 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801 |
scientific article published on 01 May 2001 |
Statements
High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801 (English)
J M Kirkwood
J G Ibrahim
J A Sosman
V K Sondak
S S Agarwala
M S Ernstoff